KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference
KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan
KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic
KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic
KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth
KORU Medical Systems Announces Successful Appeal in EU Notified Body Review
KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference
KORU Medical Announces 2023 Fourth Quarter, Full Year Financial Results
KORU Medical Announces a Feasibility Study to Enter Ambulatory Infusion Settings
KORU Medical Signs a Agreement for Phase 3 Trial with Custom Device